Dr. Maria Debiec-RychterCatholic University of Leuven. Belgium | Dr. Maria Debiec‐Rychter obtained a M.D. degree (1978) and Ph.D. degree in Somatic Genetics (1986) from the Medical University of Lodz, Poland. She remained at the University of Lodz as an Associate Professor until 1989, when she became a visiting scientist to the Michigan Cancer Foundation, Detroit, MI. Dr. Debiec‐Rychter has worked with Wayne State University, Detroit, MI and the Armed Forces Institute of Pathology, Washington, DC. She has been appointed as an Associate Professor at Catholic University of Leuven, Belgium since 1999. Her research interests are related to the cytogenetic and molecular characterization of solid tumors, and cancer related targeted therapy. Currently, she is involved in the studies of the molecular mechanisms of resistance to imatinib in GIST patients. Dr. Debiec‐Rychter is leading the Stable Disease Project. |
|---|
